5 Simple Techniques For Antidepressant agent 5
MI-CP151 was a phase 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre analyze To judge many intravenous doses of sifalimumab, in Grownup individuals with dermatomyositis or polymyositis (NCT00533091). Most important trial aims had been To guage the security and tolerability of sifalimumab in dermatomyositis or polymyosi